Quantum Computing Inc. Form 10-K Summary
Business Context and Reporting Period
Quantum Computing Inc. filed its annual report for the fiscal year ended December 31, 2021, covering the comparable year ended December 31, 2020. The company is an early-stage developer of quantum-computing software, principally Qatalyst, a hardware-agnostic platform designed to run optimization applications on conventional and quantum computers. The common stock trades on Nasdaq under “QUBT.”
Management described the company as a development-stage business with limited operations. It had 25 full-time employees, seven part-time contract staff, and six technical advisors at year-end. Revenue-generating commercialization had not yet begun.
Financial Results and Liquidity
| Metric | 2021 | 2020 | Change |
|---|---|---|---|
| Revenue | $0 | $0 | No change |
| Operating expenses | $17.13 million | $17.34 million | Down 1.23% |
| Loss from operations | $17.13 million | $17.34 million | Improved by $0.21 million |
| Net loss | $27.90 million | $24.73 million | Increased 12.8% |
| Basic and diluted loss per share | $0.96 loss | $0.88 loss | Loss increased |
| Cash used in operating activities | $6.80 million | $11.54 million | Improved by $4.74 million |
| Cash and cash equivalents at year-end | $16.74 million | $15.20 million | Increased by $1.54 million |
| Accumulated deficit | $81.39 million | $53.50 million | Increased by $27.90 million |
There was no gross profit or gross margin because the company had no revenue. Operating expenses consisted primarily of stock-based compensation of $9.40 million, research and development of $2.59 million, salaries and benefits of $2.49 million, consulting of $1.08 million, and other selling, general and administrative expenses of $1.58 million.
The net loss increase was driven principally by $10.72 million of warrant-related interest expense in 2021 versus $2.81 million in 2020, and $0.12 million of preferred dividends. The filing reports no long-term debt and no outstanding loans or convertible promissory notes at December 31, 2021. Total liabilities were $1.08 million, against stockholders’ equity of $16.20 million.
Financing activities provided $8.39 million in 2021, including $8.61 million from stock issuance. Management stated that cash and available financing resources were expected to fund operations for the next 20 to 24 months at the then-current operating level. The filing separately reports cash and equivalents of $13.23 million as of February 28, 2022.
Material Changes Versus the Prior Period
- Revenue remained zero, despite the release of two products and increased marketing and commercialization activity.
- Operating expenses declined modestly as lower stock-based compensation, consulting, legal, and other SG&A costs offset higher salaries and research and development spending.
- Research and development expense increased by approximately $1.05 million, while salary expense increased by approximately $1.85 million as the company hired additional personnel and reduced reliance on consultants.
- Operating cash burn improved substantially, primarily because of noncash stock-based compensation and warrant expenses and changes in working capital.
- The company completed a private placement of 1,545,459 shares of Series A Convertible Preferred Stock and warrants for aggregate proceeds of $8.50 million in November 2021. The preferred stock had a stated conversion price of $5.50 per common share, and the related warrants had a $7.00 exercise price.
- Common shares outstanding increased from 27.97 million at December 31, 2020 to 29.16 million at December 31, 2021. The company also reported 1.55 million Series A preferred shares outstanding at year-end.
- The $218,371 Paycheck Protection Program loan was fully forgiven in June 2021 and recognized as other income.
Guidance, Outlook, Risks, and Unusual Items
Management expected to begin generating revenue in 2022 but provided no quantified revenue, earnings, cash-flow, or margin guidance. Management attributed the delayed revenue ramp to the emerging state of quantum-computing hardware and the need to educate prospective customers and build market awareness.
The principal outlook depends on commercializing Qatalyst, expanding access to quantum processors through Amazon Braket and other partners, developing government-funded opportunities, and converting partnerships with organizations such as Splunk into commercial or research engagements. There is no assurance that these initiatives will produce material revenue or government funding.
- The company has no established revenue base, has incurred recurring losses and negative operating cash flow, and may require additional capital. Future equity or convertible-security issuances could dilute existing shareholders.
- The quantum-computing market is immature, highly competitive, technologically volatile, and subject to uncertain customer adoption. Larger competitors may have greater financial, technical, marketing, and personnel resources.
- Product commercialization depends on successfully developing reliable software, maintaining compatibility with rapidly changing quantum and conventional computing platforms, and protecting intellectual property.
- The company relies on scarce technical personnel and key executives, and failure to recruit or retain qualified employees could impair product development and commercialization.
- Cybersecurity incidents, software defects, service outages, data loss, and third-party cloud-provider issues could harm operations, reputation, and customer relationships.
- As of December 31, 2021, management concluded that disclosure controls and internal control over financial reporting were not effective. Reported material weaknesses included insufficient segregation of duties, limited accounting policies and procedures, and inadequate levels of review. Management planned to address these weaknesses through additional personnel or consultants, independent bookkeeping support, cross-approval procedures, and periodic internal audits.
- Subsequent to year-end, the company loaned QPhoton $1.25 million under a 6% unsecured note due earlier of March 1, 2023, a change of control, or an event of default. The company could be required to provide an additional $1.25 million subject to conditions. QCI and QPhoton also entered into an exclusivity agreement regarding a potential transaction.
- The filing reports no material pending litigation. It also discloses historical related-party transactions and the conversion of related-party convertible notes into common stock by December 31, 2020.
Most Important Facts for Investors to Verify
- Whether QCI generated material commercial revenue after December 31, 2021 and whether management’s expectation of 2022 revenue was achieved.
- Current cash balances, monthly cash burn, remaining runway, and the terms and availability of future financing.
- The conversion, dividend, registration, and liquidation terms of the Series A preferred stock and the potential dilution from its conversion and associated warrants.
- The full number of outstanding options, warrants, convertible securities, and other potential common-stock equivalents.
- Progress and economic terms of the QPhoton financing, exclusivity arrangement, and any proposed acquisition or strategic transaction.
- Remediation status for the material weaknesses in internal control over financial reporting.
- Whether Qatalyst and related products have achieved measurable customer adoption, recurring contracts, and commercially validated performance advantages.
- The apparent presentation inconsistencies in the extracted balance-sheet text, including duplicated or mislabeled year headings, should be checked against the filed financial statements and XBRL data.